Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Leuk Lymphoma. 2019 Jul 5;60(14):3544–3551. doi: 10.1080/10428194.2019.1623885

Table III:

Baseline patient-reported outcome stratified by clinical stage (Mayo 2012 stage) at diagnosis.

Baseline PRO
Mayo 2012 Stage
Number
of patients
(n)
Mean score
(S.D.)
P-value
FACT-G Total Score
I-II 25 76 (17) 0.36
III-IV 18 71 (13)
FACT-G PWB score
I-II 26 19 (7) 0.66
III-IV 18 20 (5)
FACT-G SWB score
I-II 26 23 (4) 0.43
III-IV 18 22 (4)
FACT-G EWB score
I-II 25 17 (4) 0.68
III-IV 18 17 (5)
FACT-G FWB score
I-II 25 16 (6) 0.020
III-IV 18 11 (6)
PROMIS GPH T-score
I-II 9 42.0 (8.1) 0.016
III-IV 9 33.3 (4.7)
PROMIS GMH T-score
I-II 9 47.1 (7.3) 0.10
III-IV 9 41.6 (5.1)

Abbreviations: PRO: Patient-reported outcome; SD: Standard deviation; FACT-G: Functional Assessment of Cancer Therapy-General; PWB: Physical Well Being; SWB: Social Well Being; EWB: Emotional Well Being; FWB: Functional Well Being; GPH: Global Physical Health; GMH: Global Mental Health; PROMIS: Patient-Reported Outcome Measurement Information System